HEALTHCARE TRIANGLE, INC. (HCTI) Spending and interest coverage
- R&D / revenue · 12 months: Value 1.85%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 1.85% | Research and development expense / revenue. Period ending 2026-06-30. $474.00K ÷ $25.67M × 100 ≈ 1.85% |
| Stock-based compensation / revenue · 12 months | (m) | Share-based compensation / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 474.00K USD | Research and Development Expense |
| Revenue | 25.67M USD | |
| Stock-based compensation | (m) | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -14.73M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $474.00K | $25.67M | (m) | $-14.73M | (m) | 1.85% | (m) | (m) | (m) |
| 2026-03-31 | $477.00K | $20.04M | (m) | $-12.01M | (m) | 2.38% | (m) | (m) | (m) |
| 2025-12-31 | $536.00K | $13.89M | $451.00K | $-9.79M | $567.00K | 3.86% | 3.25% | -17.26× | Reported |
| 2025-09-30 | $177.00K | $12.94M | $432.00K | $-5.84M | (m) | 1.37% | 3.34% | (m) | (m) |
| 2025-06-30 | $293.00K | $11.87M | $72.00K | $-4.42M | (m) | 2.47% | 0.61% | (m) | (m) |
| 2025-03-31 | $446.00K | $11.29M | $97.00K | $-4.44M | (m) | 3.95% | 0.86% | (m) | (m) |
| 2024-12-31 | $429.00K | $11.70M | $87.00K | $-4.75M | (m) | 3.67% | 0.74% | (m) | (m) |
| 2024-09-30 | $613.00K | $16.57M | $-74.00K | $-9.27M | (m) | 3.70% | -0.45% | (m) | (m) |
| 2024-06-30 | $492.00K | $21.93M | $-109.00K | $-9.63M | (m) | 2.24% | -0.50% | (m) | (m) |
| 2024-03-31 | $387.00K | $27.47M | $-99.00K | $-9.85M | (m) | 1.41% | -0.36% | (m) | (m) |
| 2023-12-31 | $799.00K | $33.20M | $17.00K | $-11.35M | (m) | 2.41% | 0.05% | (m) | (m) |
| 2023-09-30 | $3.46M | $37.44M | (m) | $-11.28M | $746.00K | 9.26% | (m) | -15.12× | Reported |
| 2023-06-30 | $4.88M | $41.61M | (m) | $-11.81M | $386.00K | 11.73% | (m) | -30.60× | Reported |
| 2023-03-31 | $5.43M | $44.67M | (m) | $-11.65M | $258.00K | 12.15% | (m) | -45.16× | Reported |
| 2022-12-31 | $5.95M | $45.89M | (m) | $-10.42M | $212.00K | 12.97% | (m) | -49.13× | Reported |
| 2022-09-30 | $4.67M | $43.78M | (m) | $-8.99M | $215.74K | 10.66% | (m) | -41.69× | Reported |
| 2022-06-30 | $5.40M | $39.91M | (m) | $-8.52M | $381.74K | 13.53% | (m) | -22.31× | Reported |
| 2022-03-31 | $5.57M | $38.37M | (m) | $-6.62M | $487.74K | 14.51% | (m) | -13.57× | Reported |
| 2021-12-31 | $5.26M | $35.27M | (m) | $-5.36M | $566.74K | 14.91% | (m) | -9.46× | Reported |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $1.74M | $31.34M | (m) | $1.18M | $78.65K | 5.56% | (m) | 14.96× | Reported |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Super League Enterprise, Inc. (SLE) | United States | $0.009B | -0.20 |
| Fusemachines Inc. (FUSE) | United States | $0.017B | |
| Algorhythm Holdings, Inc. (RIME) | United States | $0.003B | -0.61 |
| CREATIVE REALITIES, INC. (CREX) | United States | $0.036B | -2.64 |
| STEM, INC. (STEM) | United States | $0.038B | -1.03 |
| Brand Engagement Network Inc. (BNAI) | United States | $0.048B | |
| Odysight.ai Inc. (ODYS) | $0.054B | -3.84 | |
| CSP INC /MA/ (CSPI) | United States | $0.077B | -117.69 |
| CID Holdco, Inc. (DAIC) | United States | $0.103B | |
| WIDEPOINT CORP (WYY) | United States | $0.109B | -137.61 |